Opthea Appoints Hamish George As CFO
(RTTNews) - Opthea Ltd. (OPT.AX, OPT), a clinical-stage biopharmaceutical company, Monday announced the appointment of Hamish George as Chief Financial Officer, effective today.
The company also stated that Stephanie Vipond of Bio101 will assume the role of Joint Company Secretary in place of Karen Adams, effective today.
Together, George and Vipond are responsible for communication between the Company and ASX.
In the pre-market activity, shares are trading at $3.41 on the Nasdaq.
Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges.